Kelly James Patrick

CIK 00015063143 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001506314

Recent Transactions

50 trades

Tax Payment
NOVAVAX INC$NVAX
Common Stock
2025-03-07$8.34/sh−5,904→ 69,251 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2025-03-07+12,223→ 75,155 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2025-03-07−12,223→ 12,223 total
Award
NOVAVAX INC$NVAX
2025 Restricted Stock Units RSU
2025-03-03+129,500→ 129,500 total
Award
NOVAVAX INC$NVAX
2025 Non-statutory Stock Option NQ
2025-03-03$7.87/sh+194,500→ 194,500 total
Tax Payment
NOVAVAX INC$NVAX
Common Stock
2025-03-01$8.33/sh−28,337→ 62,932 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2025-03-01−58,667→ 117,333 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2025-03-01+58,667→ 91,269 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2024-12-31+35,000→ 49,508 total
Tax Payment
NOVAVAX INC$NVAX
Common Stock
2024-12-31$8.04/sh−16,906→ 32,602 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2024-12-31−35,000→ 0 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2024-08-16−2,367→ 0 total
Tax Payment
NOVAVAX INC$NVAX
Common Stock
2024-08-16$12.96/sh−1,223→ 14,429 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2024-08-16$12.96/sh+2,367→ 15,652 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2024-03-10−4,608→ 4,608 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2024-03-10+4,608→ 15,511 total
Tax Payment
NOVAVAX INC$NVAX
Common Stock
2024-03-10$5.45/sh−2,226→ 13,285 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2024-03-07−12,224→ 24,446 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2024-03-07+12,224→ 16,808 total
Tax Payment
NOVAVAX INC$NVAX
Common Stock
2024-03-07$5.61/sh−5,905→ 10,903 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2024-03-01+176,000→ 176,000 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2023-09-12−35,000→ 35,000 total
Tax Payment
NOVAVAX INC$NVAX
Common Stock
2023-08-16$7.13/sh−1,143→ 4,584 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2023-08-16−2,366→ 2,367 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2023-08-16+2,366→ 5,727 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2023-03-10$6.52/sh+4,609→ 5,832 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2023-03-10−4,609→ 9,216 total
Tax Payment
NOVAVAX INC$NVAX
Common Stock
2023-03-10$6.52/sh−2,471→ 3,361 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2023-03-07+42,350→ 42,350 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2023-03-07+36,670→ 36,670 total
Exercise/Conversion
NOVAVAX INC$NVAX
Restricted Stock Units
2022-08-16−2,367→ 4,733 total
Tax Payment
NOVAVAX INC$NVAX
Common Stock
2022-08-16$42.88/sh−1,144→ 1,223 total
Exercise/Conversion
NOVAVAX INC$NVAX
Common Stock
2022-08-16+2,367→ 2,367 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2022-03-10+13,825→ 13,825 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2022-03-10+20,737→ 20,737 total
Award
NOVAVAX INC$NVAX
Stock Option (Right to Buy)
2021-08-16+14,200→ 14,200 total
Award
NOVAVAX INC$NVAX
Restricted Stock Units
2021-08-16+7,100→ 7,100 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2021-02-19+15,000→ 15,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2020-10-12+135,000→ 135,000 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-03-03$10.76/sh−5,889→ 186,869 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-03-02$10.19/sh−12,968→ 192,758 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-01-02$15.94/sh−4,020→ 205,726 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-03-04$19.88/sh−8,751→ 209,746 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-03-01$20.15/sh−4,976→ 218,497 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2019-02-27+70,000→ 70,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-02-27+30,000→ 223,473 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-01-03$26.09/sh−1,619→ 193,473 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-01-02$26.94/sh−1,129→ 195,092 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-01-02$26.31/sh−3,313→ 196,221 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-03-01$18.72/sh−8,532→ 199,534 total

Companies

Recent Filings

Address

9605 MEDICAL CENTER DRIVE SUITE 300

ROCKVILLE, MD, 20850

View on SEC.gov